Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Amgen    AMGN

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets
Latest Tweets
10:38aAmgen Inc. $AMGN Shares Sold by Kovitz Investment Group Partners LLC  
10:38aArrow Financial Corp Sells 692 Shares of Amgen Inc. $AMGN  
01:30a#Amgen teamed up with @RachaelRayShow to help you talk to your doctor about #.. 
10/18Shire feels Amgen's Restasis patent pain, shares down 3%  
10/18Amgen utilizes a fit-for-purpose approach to drug design. See how #proteineng..
10/18Arthur Hill: Three Pullbacks for Three Healthcare Stocks $GILD $AMGN $MRK  
10/18Arthur Hill: Three Pullbacks for Three Healthcare Stocks $GILD $AMGN $MRK  
10/18Setups and thoughts on major markets for today, and every day: $SPY $DIA $KO.. 
10/18Amgen Inc. $AMGN Holdings Lifted by Financial Advisory Service Inc.  
10/18Q3 2017 Earnings Forecast for Amgen Inc. Issued By Leerink Swann $AMGN  
10/17SWING TRADE ALERT: Recent $AMGN technical alerts: Non-ADX 1,2,3,4 Bullish plu.. 
10/17Get the latest ratings for $SKYS $AMGN $POFCF $ITRN $GROUF in your inbox with.. 
10/17[forum discussion]New neuro sales force for Amgen migraine drug erenumab: Caf.. 
10/17How well do you know Amgen’s #biotech #manufacturing process? Find out by tak..
10/17British Airways Pensions Investment Management Ltd Maintains Stake in Amgen I.. 
10/17$AMGN - Barclays PLC Boosts Amgen Inc. #AMGN Price Target to $190.00  
10/17Amgen And Boston Children's Hospital Enter A Collaboration To Find New Genes .. 
10/17$AMGN: Amgen and the Boston Children's hospital have entered into a neuroscie.. 
10/16Amgen teams up with Boston Children's Hospital to identify new pain targets  
10/16BRIEF-Amgen and Boston Children's Hospital enter into neuroscience research c.. 
10/16Today #Amgen & @BostonChildrens announce collaboration to validate geneti..
10/16$AMGN Amgen And Boston Children's Hospital Enter A Collaboration To Find New .. 
10/16Trust Investment Advisors Has $1,405,000 Stake in Amgen Inc. $AMGN  
10/16Amgen Inc. $AMGN Shares Bought by Cambridge Trust Co.  
10/16Cullen Frost Bankers Inc. Has $8.98 Million Stake in Amgen Inc. $AMGN  
10/16Perennial Advisors LLC Grows Stake in Amgen Inc. $AMGN  
10/15Rand Wealth LLC Has $351,000 Holdings in Amgen Inc. $AMGN  
10/15Analysts Offer Insights on Healthcare Companies: Acelrx (NASDAQ: ACRX) and Am.. 
10/14Amgen Inc. $AMGN Given New $190.00 Price Target at Barclays PLC  
10/14Mercer Capital Advisers Inc. Has $893,000 Stake in Amgen Inc. $AMGN  
10/14Amgen $AMGN Getting Somewhat Positive Press Coverage, Study Shows  
10/14$AMGN - Amgen #AMGN Getting Somewhat Positive Press Coverage, Study Shows  
10/14#Amgen @LabCental offer free mentoring, equipment, training …& lab space..
10/13Amgen Inc Gets a Buy Rating from Mizuho Securities $AMGN  
10/13Amgen Inc Gets a Hold Rating from Barclays $AMGN  
10/13Insider Selling: Amgen Inc. $AMGN EVP Sells $283,573.75 in Stock  
10/13In case you were wondering about that CETP inhibitor $AMGN bought with Dezima..
10/13Amgen Inc. $AMGN Shares Bought by Enterprise Financial Services Corp  
10/12Amgen Foundation Awards Khan Academy $3 Million To Support Development Of Fre.. 
10/12$AMGN Amgen Foundation Awards Khan Academy $3 Million To Support Development .. 
10/12Smith Affiliated Capital Corp. Holds Position in Amgen Inc. $AMGN  
10/11$AMGN CEO Bradway to be next chair @PhRMA, effective Feb 2018:
10/11Amgen Chairman and CEO Robert A. Bradway Elected PhRMA Board Chairman-Elect  
10/11#ovariancancer Dedicated Amgen Employees Work Despite Personal Losses From: E.. 
10/11Amgen Inc. Expected to Earn Q3 2017 Earnings of $3.16 Per Share $AMGN  
10/11Amgen Puerto Rico staff keeping plant open despite personal losses from Hurri..
More tweets
Financials ($)
Sales 2017 22 862 M
EBIT 2017 11 817 M
Net income 2017 8 137 M
Finance 2017 4 380 M
Yield 2017 2,44%
P/E ratio 2017 16,62
P/E ratio 2018 16,30
EV / Sales 2017 5,68x
EV / Sales 2018 5,55x
Capitalization 134 B
Duration : Period :
Amgen Technical Analysis Chart | AMGN | US0311621009 | 4-Traders
Technical analysis trends AMGEN
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 191 $
Spread / Average Target 3,5%
EPS Revisions
Robert A. Bradway Chairman & Chief Executive Officer
Esteban Santos Executive Vice President-Operations
David W. Meline Executive VP, Chief Financial & Accounting Officer
Sean E. Harper Executive Vice President-Research & Development
Paul R. Eisenberg Chief Medical Officer & Senior VP-Global Medical
Sector and Competitors
1st jan.Capitalization (M$)
AMGEN27.41%135 924
JOHNSON & JOHNSON22.11%377 585
NOVARTIS13.50%226 453
ROCHE HOLDING LTD.5.55%215 760
PFIZER10.31%213 372